Navigation Links
Scripps scientists develop test providing new pathway for identifying obesity, diabetes drugs
Date:9/16/2010

La Jolla, CA, September 15, 2010 Scientists at The Scripps Research Institute have designed a new molecular test that will allow researchers to look for potential drugs targeting a human metabolic enzyme believed to stimulate the appetite and play a role in diabetes.

The new test, which the scientists call a simple assay, will allow researchers to look through hundreds of thousands of compounds for those that have potential to block the action of an enzyme known as ghrelin O-acyltransferase (GOAT). If drugs can be found that safely suppress the action of GOAT, they may help people who have clinical problems with appetite, obesity, and diabetes.

"There hasn't been a simple screen until now," says Kim D. Janda, Ph.D., a professor in the Departments of Chemistry and Immunology and Microbial Science, member of The Skaggs Institute for Chemical Biology, and director of The Worm Institute for Research and Medicine at Scripps Research.

Janda and Amanda Garner, Ph.D., a research associate in his laboratory, describe the new approachwhich may also prove useful for investigating other enzymes involved in a variety of diseasesin an advance, online Early edition of the journal Angewandte Chemie on September 15, 2010.

A Tempting Target

Even though GOAT was only discovered recently, in 2008, scientists had speculated for years that it had to exist. After all, its target (ghrelin, or the "G" in the acronym GOAT) had been known for more than a decade.

Ghrelin, a small peptide hormone that is mainly produced in the stomach, signals hunger, typically before meals. Ghrelin has been associated with Prader-Willi syndrome a common genetic cause of childhood obesity in which patients have exceptionally high ghrelin levels.

The biology of ghrelin is quite intricate. For ghrelin to impact the body's metabolism, it must move from the stomach to the brain, where it acts on neurons. GOAT acts as a "passport" check point station for the processing of 'pro-ghrelin.'

"Without GOAT's modification of 'pro-ghrelin,' ghrelin's entry into the brain, and thus its medicinal implications, are nullified," said Janda. "That's why GOAT has been coveted as a promising therapeutic target for obesity and diabetes."

However, the task of finding drug-like compounds that target GOAT has been complicated by the fact that the enzyme is difficult to work with. As a membrane-bound protein, GOAT cannot easily be purified to homogeneity and has to be suspended in a fatty environment.

Most critically, however, no user-friendly high-throughput screening tests had been developed for this class of enzymes. Current assay technology for targets similar to GOAT rely on radiolabeling techniques, which are labor-intensive and require additional safety precautions.

When Janda and Garner set out to develop an assay to monitor GOAT's activity, they aimed to change this situation.

Taking a Fresh Approach

The scientists were particularly interested in designing a fluorescence-based assay for GOAT. In contrast to radiolabeling techniques, fluorescence assays are safe, can easily be performed in a high-throughput format, and require only a simple light source.

In developing their new approach, the team was inspired by enzyme immunoassay strategies commonly used in biology, chemistry, and medicine, and by "click chemistry," a concept developed at Scripps Research. Because the amount of ghrelin modified by GOAT is minute, the scientists also used the principle of multi-turnover signal amplification for accurate detection.

In the end, the team succeeded in designing and creating the new technologywhich they call "catalytic assay using enzyme-linked click chemistry assay" (cat-ELCCA).

"This new assay technology is both highly sensitive and reproducible," noted Janda, "making it an excellent assay for high-throughput screening."

Janda and Garner are now further developing the assay so that researchers can screen thousands to millions of compounds at once against the activity of GOAT.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

Related biology news :

1. Scripps research team wins $5.1 million to develop DNA sequencing technology
2. Team led by Scripps Research scientist identifies new gene for memory
3. Seafood stewardship questionable: UBC-Scripps experts
4. UCI-Scripps study links cellular motors to memory
5. Scripps Research scientists uncover new mechanism of memory formation
6. Scripps Oceanography biologists awarded prestigious honors
7. Scripps Research scientists uncover possible cocaine addiction trigger
8. Scripps research study opens the door to new class of drugs for epileptic seizures
9. Scripps research study shows infectious prions can arise spontaneously in normal brain tissue
10. Scripps Research scientists find new way to attack cancerous cells
11. Scripps research scientists determine structure of immune molecule that counteracts HIV strains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
(Date:6/9/2016)... innovation leader in attendance control systems is proud to announce the introduction of fingerprint ... sure the right employees are actually signing in, and to even control the opening ... ... ... Photo ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 01, 2016 , ... ... Symposium (CSS) and the popularity of US Single Day Events (SDE) to organize ... early Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences ...
(Date:12/2/2016)... CHICAGO, IL (PRWEB) , ... December 01, 2016 ... ... pleased to congratulate long-term client Nanowear on their recent FDA Class II 510(k) ... has cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely ...
(Date:12/2/2016)... --  SurePure, Inc. (OTCQB: SURP) a global leader ... concluded an agreement with Tamarack Biotics under which Tamarack ... acquire units of the Company,s patented photopurification technology with ... Concurrently with the option, SurePure has entered ... seek regulatory approvals in the United States ...
(Date:11/30/2016)... ... 30, 2016 , ... BEI Kimco, a brand of Sensata ... design that ensures high alignment accuracy by preventing unwanted shaft rotation. The new ... extreme precision is required, such as in medical equipment, laboratory instrumentation, clean rooms, ...
Breaking Biology Technology: